Forum

Drug Alert: Eprex (recombinant human erythropoeitin alfa) and pure red cell aplasia - recommendations for administration to patients with CRF

Bookmark and Share
National Adverse Drug Monitoring Centre, Medicines Control Council

Author's affiliations

National Adverse Drug Monitoring Centre, Medicines Control Council, HMPG

Full Text

PDF (192KB)

Cite this article

South African Medical Journal 2003;93(11):839.

Article History

Date submitted: 2008-07-30
Date published: 2008-07-30

Article Views

Abstract views: 967
Full text views: 1396

Comments on this article

*Read our policy for posting comments here